Greenhaven Associates’s Genpact G Stock Holding History

Greenhaven Associates’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Hold	10,000	–	–	﹤0.01%	28
2026 Q1	$373K	Hold	10,000	–	–	0.01%	26
2025 Q4	$468K	Hold	10,000	–	–	0.01%	29
2025 Q3	$419K	Sell	10,000 -1,018	-9%	-$44.8K	0.01%	26
2025 Q2	$485K	Sell	11,018 -135,660	-92%	-$6.14M	0.01%	23
2025 Q1	$7.39M	Sell	146,678 -1,083,660	-88%	-$53.7M	0.12%	16
2024 Q4	$52.8M	Sell	1,230,338 -13,475	-1%	-$569K	0.78%	14
2024 Q3	$48.8M	Buy	1,243,813 +3,038	+0.2%	+$110K	0.57%	15
2024 Q2	$39.9M	Buy	1,240,775 +153,140	+14%	+$4.94M	0.52%	16
2024 Q1	$35.8M	Buy	1,087,635 +784,830	+259%	+$27.3M	0.33%	19
2023 Q4	$10.5M	Buy	+302,805	New	+$10.4M	0.11%	20

Other funds holding G

NIEF

Nalanda India Equity Fund Mauritius $377M AUM 37.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Greenhaven Associates's G Position: Q2 2026 in Review

Greenhaven Associates held its Genpact (G) position steady in Q2 2026 at 10,000 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #28.

Greenhaven Associates first reported a position in G in Q4 2023 and has held it in 11 quarters since. The position peaked at $52.8M in Q4 2024. 192 funds tracked by Wall St. Rank hold G as of Q2 2026.

Greenhaven Associates held 10,000 shares of Genpact worth $275K as of Q2 2026.
Greenhaven Associates left its Genpact share count unchanged in Q2 2026.
Genpact made up ﹤0.01% of Greenhaven Associates's portfolio in Q2 2026, its #28 holding.
Greenhaven Associates first reported a position in Genpact in Q4 2023 and has held it in 11 quarters since.
Greenhaven Associates's Genpact position peaked at $52.8M in Q4 2024.
192 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Greenhaven Associates's 13F filing for Q2 2026, filed 28 Jul 2026.